Nuclear receptor PPARγ targets GPNMB to promote oligodendrocyte development and remyelination - Summary - MDSpire

Nuclear receptor PPARγ targets GPNMB to promote oligodendrocyte development and remyelination

  • By

  • Bing Han

  • Ming-Yue Bao

  • Qing-Qing Sun

  • Rui-Ning Wang

  • Xin Deng

  • Kun Xing

  • Feng-Lin Yu

  • Yan Zhang

  • Yue-Bo Li

  • Xiu-Qing Li

  • Na-Nan Chai

  • Gai-Xin Ma

  • Ya-Na Yang

  • Meng-Yuan Tian

  • Qian Zhang

  • Xing Li

  • Yuan Zhang

  • January 6, 2025

  • 0 min

Share

Objective:

To investigate the role of PPARγ in oligodendrocyte precursor cell (OPC) differentiation and remyelination in the central nervous system (CNS).

Key Findings:
  • PPARγ is enriched in dysfunctional OPCs in CNS demyelinated lesions.
  • PPARγ expression increases during OPC differentiation and myelination.
  • PPARγ agonists significantly promote OPC differentiation and enhance remyelination.
  • Knockout of PPARγ in oligodendrocytes leads to decreased OPC maturation and myelin generation.
  • GPNMB is identified as a downstream target of PPARγ that regulates OPC differentiation.
Interpretation:

PPARγ acts as a positive regulator of OPC differentiation and CNS remyelination, suggesting its potential as a therapeutic target for CNS regenerative therapies.

Limitations:
  • The study primarily focuses on animal models, which may not fully replicate human CNS conditions.
  • Further research is needed to explore the long-term effects of PPARγ modulation on remyelination.
Conclusion:

PPARγ and its downstream effector GPNMB may serve as promising pharmacological targets for enhancing remyelination in demyelinating diseases.

Original Source(s)

Nuclear receptor PPARγ targets GPNMB to promote oligodendrocyte development and remyelination

  • by Bing Han, Ming-Yue Bao, Qing-Qing Sun, Rui-Ning Wang, Xin Deng, Kun Xing, Feng-Lin Yu, Yan Zhang, Yue-Bo Li, Xiu-Qing Li, Na-Nan Chai, Gai-Xin Ma, Ya-Na Yang, Meng-Yuan Tian, Qian Zhang, Xing Li, Yuan Zhang

  • January 6, 2025

Related Content

Associations of Serum Alpha-Linolenic Acid with Disability and Brain Volume in Multiple Sclerosis: A Concise Replication Study

Multiple sclerosis as a biological and clinical continuum: from risk factors to the early stages of disease

Non-Linear Measures of Movement Variability in Multiple Sclerosis: A Clinical Narrative Review of Lyapunov Exponent and Entropy Applications in Balance and Gait